End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | 308M 24.19B | Sales 2025 * | 334M 26.29B | Capitalization | 1.01B 79.25B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 4 x |
Net Debt 2024 * | 224M 17.64B | Net Debt 2025 * | 145M 11.39B | EV / Sales 2025 * | 3.45 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 65.49% |
Latest transcript on Theravance Inc
Managers | Title | Age | Since |
---|---|---|---|
Pavel Raifeld
CEO | Chief Executive Officer | 40 | 19/05/20 |
Stephen Basso
DFI | Director of Finance/CFO | 58 | 20/08/23 |
Marianne Zhen
AUD | Comptroller/Controller/Auditor | 55 | 30/09/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 11/02/18 | |
Director/Board Member | 53 | 31/12/22 | |
Jules Haimovitz
BRD | Director/Board Member | 73 | 11/02/18 |
1st Jan change | Capi. | |
---|---|---|
+34.35% | 705B | |
+29.39% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.11% | 238B | |
-3.03% | 210B | |
+10.02% | 209B | |
+9.21% | 169B |